Delivery Order SPE2DB22D2108-SPE2DB25FU3DA

Award Date 1/14/25
Potential Completion Date 1/15/25
Potential Value $5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,778.86 Firm Fixed Price contract is for the supply of 4,567,152,479 units of Tamsulosin HCL 0.4 mg capsules. The contract has a completion date of February 5, 2025 and was awarded on February 4, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,796.09, is for the delivery of 4,566,770,572 units of the drug Tamsulosin HCl 0.4 mg capsules. The contract is a Firm Fixed Price Delivery Order with a completion date of December 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,530.81 firm fixed-price delivery order is for the supply of 4,562,264,266 Tamsulosin HCl 0.4 mg capsules. The contract has an ultimate completion date of September 22, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,561,823,091 units of Tamsulosin HCL 0.4 mg capsules. The contract has a firm fixed price of $5,949.44 and an ultimate completion date of August 16, 2023. The contract was awarded on August 15, 2023 and was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,544,849 units of Tamsulosin HCL 0.4 mg capsules. The contract has a ceiling value of $5,142.60 and a period of performance through November 26, 2024. This appears to be a Firm Fixed Price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,065.94, is for the supply of 4,567,222,444 units of Tamsulosin HCL 0.4 mg capsules. The contract has a firm fixed-price pricing type and a completion date of February 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,257.96, is for the delivery of 4,566,700,582 units of the drug Tamsulosin HCl 0.4 mg capsules. The contract is a firm fixed-price delivery order with a completion date of December 13, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract award, valued at $9,247.32, is for the delivery of 1000 units of the drug Tamsulosin HCL 0.4 mg capsules. The contract is a Firm Fixed Price Delivery Order with a completion date of September 20, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,096.99, is for the delivery of 4,567,327,770 units of Tamsulosin HCL 0.4 mg capsules. The contract is a firm fixed-price delivery order with a completion date of February 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,865.14, is for the delivery of 1,000 units of the medication Tamsulosin HCL 0.4 mg capsules. The contract has an ultimate completion date of November 21, 2023 and is a firm fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
  • SPE2DB22D2108
    Indefinite Delivery Contract
  • SPE2DB22D2108-SPE2DB25FU3DA
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $5,011.02 for the provision of 4,566,929,250 units of Tamsulosin HCL 0.4 mg capsules. The contract has an ultimate completion date of January 15, 2025 and is a Firm Fixed Price arrangement. This award is not designated under a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/21/25, 9:54 AM